Fort Lauderdale, Fla., November 26, 2024 - PRISM MediaWire - SS Innovations (OTC: SSII) achieves a milestone with the first robotic cardiac surgery in Indonesia, showcasing the potential of its cost-effective SSi Mantra Surgical Robotic System to transform cardiac care globally.
Facts:
- Successful Procedure: Dr. Sudhir Srivastava, founder of SS Innovations, successfully performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia using the SSi Mantra system. This took place at Harapan Kita National Cardiac Hospital in Jakarta, marking a significant advancement for Indonesian healthcare.
- SSi Mantra System: The SSi Mantra is a modular, multi-arm robotic system designed to make robotic surgery affordable and accessible globally. Its features include 3-5 robotic arms, an ergonomic Surgeon Command Centre, 3D 4K monitors, and a wide range of compatible surgical instruments.
- Cost-effectiveness and Accessibility: The SSi Mantra system is highlighted as a cost-effective solution compared to other robotic surgical systems. This affordability is crucial for making advanced surgical techniques accessible to a larger population, particularly in developing nations.
- Global Expansion: SS Innovations aims to expand its presence globally. They have started the regulatory process for approval in the United States and European Union, with anticipated approval in the second half of 2025.
Chairman, and CEO, Dr. Sudhir Srivastava
"We are proud to partner with Harapan Kita National Cardiac Hospital to bring the most technologically advanced and cost-effective solutions to cardiac surgery to Indonesia... This collaboration addresses the critical need for safe, timely, and affordable cardiac care while offering patients less invasive options and an improved quality of life."
SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava
"We found that the SSi Mantra is the only system supporting the full spectrum of robotic cardiac surgery, including Totally Endoscopic Coronary Artery Bypass (TECAB). Given its unique capabilities, we invited Dr. Srivastava’s team to demonstrate how the SSi Mantra performs as compared to other systems. The potential for implementing robotic surgery in our country is highly promising."
Dr. Iwan Dakota, Director and Intervention Cardiologist at NCVC Harapan Kita
Significance:
- Advancement in Indonesian Healthcare: The introduction of robotic cardiac surgery signifies a major step forward for Indonesia's healthcare system, potentially improving patient outcomes and quality of care.
- India as a Hub for MedTech Innovation: The development and success of the SSi Mantra system highlights India's growing role as a leader in medical technology innovation.
- Increased Access to Robotic Surgery: SS Innovations' focus on cost-effectiveness could democratize access to advanced robotic surgery, making it available to patients worldwide who might not otherwise have access to such treatments.
Next Steps:
- Further Research and Development: Continued research and development of the SSi Mantra system are essential to enhance its capabilities and ensure its competitiveness in the global market.
- Market Expansion: Aggressive marketing and expansion efforts are needed to introduce the SSi Mantra system to new markets, including the United States and Europe.
- Training and Education: Providing comprehensive training and education to surgeons worldwide will be crucial for the successful adoption and utilization of the SSi Mantra system.
About SS Innovations:
SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SS Innovations’ business operations are headquartered in India and the Company plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit our website at ssinnovations.com or LinkedIn for updates.
SSI Mantra Surgical Robotic System by SS Innovations
About SSI Mantra:
The SSI Mantra Surgical Robotic System, by SS Innovations, is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the Surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including cardiac surgery. The learning curve for surgeons is shorter due to the SSi Mantra’s ergonomic design and user-friendly features.
The SSi Mantra has been clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Follow us on:
For media inquiries, please contact:
+1-212-739-0300
Source: SS Innovations International, Inc.